Painful diabetic peripheral neuropathy

Current Therapy in Pain

Volumn , Issue , 2009, Pages 250-255

  Fernandez, Vania E ^a,b   Abdi, Salahadin ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b JACKSON MEMORIAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84883995066     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-1-4160-4836-7.00034-1     Document Type: Chapter

References (43)

1. Eastman RC. Neuropathy in diabetes. Diabetes in America, 2nd ed. National Diabetes Information Clearinghouse, pp 339-348. Bethesda, MD, 1995. Available at . http://www.diabetes.niddk.nih.gov/dm/pubs/america/contents.htm.
2. Boulton AJ, Vinik AI, Arrezo JC, et al. Diabetic neuropathies: a statement by the American Diabetes Association. Diabetes Care 2005, 28:956-962.
3. Argoff CE, Eliot Cole B, Fishbain DA, Irving GA Diabetic peripheral neuropathic pain: clinical and quality-of-life issues. Mayo Clin Proc 2006, 81(4 suppl):S3-S11.
4. Thomas PK Diabetic peripheral neuropathies: their cost to patient and society and the value of knowledge of risk factors for development of interventions. Eur Neurol 1999, 41(suppl 1):35-43.
5. Gooch C, Podwall D The diabetic neuropathies. Neurologist 2004, 10:311-322.
6. Dyck PJ, Kratz KM, Karnes JL, et al. The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population-based cohort. Neurology 1993, 43:817-824.
7. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med 1993, 329:977-986.
8. Partanen J, Niskanen L, Lehtinen J, et al. Natural history of peripheral neuropathy in patients with non-insulin dependent diabetes. N Engl J Med 1995, 333:39-84.
9. Singleton JR, Smith AG, Bromberg MB Painful sensory polyneuropathy associated with impaired glucose tolerance. Muscle Nerve 2001, 24:1109-1112.
10. Dyck PJ, Davies JL, Wilson DM, et al. Risk factors for severity of diabetic polyneuropathy: intensive longitudinal assessment of the Rochester Diabetic Neuropathy Study cohort. Diabetes Care 1999, 22:1479-1486.
11. Cryer PE Glucose homeostasis and hypoglycemia. Williams Textbook of Endocrinology 2008, Saunders Elsevier, Philadelphia. 11th. H.M. Kronenberg, S. Melmed, K.S. Polonsky, P.R. Larsen (Eds.).
12. Malik RA, Tesfaye S, Thompson SD, et al. Endoneurial localization of vascular damage in human diabetic neuropathy. Diabetologia 1993, 36:454-459.
13. Capo H, Warren F, Kupersmith MJ Evolution of occulomotor nerve palsies. J Clin Neuroophthalmol 1992, 12:21-25.
14. Perkins B, Olaeye BV Carpal tunnel syndrome in patients with diabetic neuropathy. Diabetes Care 2001, 25:565-569.
15. Kapritsaya Y, Novak C, Mackinnon S Prevalence of smoking, obesity, diabetes and thyroid disease in patients with carpal tunnel syndrome. Ann Plast Surg 2002, 48:269-279.
16. Dyck PJB, Windebank AJ Diabetic and nondiabetic lumbosacral radiculoplexus neuropathies: new insights into pathophysiology and treatment. Muscle Nerve 2002, 25:477-491.
17. Tarulli AW, Raynor EM Lumbosacral radiculopathy. Neurol Clin 2007, 25:387-405.
18. The effect of intensive diabetes therapy on the development and progression of neuropathy. Ann Intern Med 1995, 122:561-568. Diabetes Control and Complications Trial Research Group.
19. Haythornthwaite JA, Benrud-Larson LM Psychological aspects of neuropathic pain. Clin J Pain 2000, 16(suppl):S101-S105.
20. Backonja M, Beydoun A, Edwards KR, et al. Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: a randomized controlled trial. JAMA 1998, 280:1831-1836. , and the Gabapentin Diabetic Neuropathy Study Group.
21. The effect of intensive diabetes therapy on the development and progression of neuropathy. Ann Intern Med 1995, 122:561-568. Diabetes Control and Complications Trial Research Group.
22. Saarto T, Wiffen PJ Antidepressants for neuropathic pain. Cochrane Database Syst Rev 2005, (3). CD005454.
23. Dworkin RH, Backonja M, Rowbotham MC, et al. Advances in neuropathic pain: diagnosis, mechanisms, and treatment recommendations. Arch Neurol 2003, 60:1524-1534.
24. Rull JA, Quibrera R, González-Millán H, Lozano Castañeda O Symptomatic treatment of peripheral diabetic neuropathy with carbamazepine (Tegretol): double blind crossover trial. Diabetologia 1969, 5:215-218.
25. Blom S Trigeminal neuralgia: its treatment with a new anticonvulsant drug (G-32883). Lancet 1962, 21:839-840.
26. Wilton TD Tegretol in the treatment of diabetic neuropathy. S Afr Med J 1974, 48:869-872.
27. Gomez-Perez FJ, Choza R, Rios JM, et al. Nortriptyline-fluphenazine vs. carbamazepine in the symptomatic treatment of diabetic neuropathy. Arch Med Res 1996, 27:525-529.
28. Knotkova H, Papagallo M Adjuvant analgesics. Med Clin North Am 2007, 91:113-124.
29. Devers A, Galer BS Topical lidocaine patch relieves a variety of neuropathic pain conditions: an open-label study. Clin J Pain 2000, 16:205-208.
30. Hart-Gouleau S, Gammaitoni A, Galer B, et al. Open label study of the effectiveness and safety of lidocaine patch 5% (Lidoderm) in patients with painful diabetic neuropathy. Pain Med 2005, 6:379-384.
31. Tremont-Lukats IW, Challapalli V, McNicol ED, et al. Systemic administration of local anesthetics to relieve neuropathic pain: a systematic review and meta-analysis [see comment]. Review. Anesth Analg 2005, 101:1738-1749.
32. Jarvis B, Coukell AJ Mexiletine. A review of its therapeutic use in painful diabetic neuropathy. Review. Drugs 1998, 56:691-707.
33. Rains C, Bryson HM Topical capsaicin: a review of its pharmacological properties and therapeutic potential in post-herpetic neuralgia, diabetic neuropathy and osteoarthritis. Drugs Aging 1995, 7:317-328.
34. Kolesnikov YA, Chereshnev I, Pasternak GW Analgesic synergy between topical lidocaine and topical opioids. J Pharmacol Exp Ther 2000, 295:546-551.
35. Hollingshead J, Duhmke RM, Cornblath DR Tramadol for neuropathic pain. Cochrane Database Syst Rev 2004, (2). CD003726.
36. Hays L, Reid C, Doran M, Geary K Use of methadone for the treatment of diabetic neuropathy. Diabetes Care 2005, 28:485-487.
37. Hocking G, Cousins MJ Ketamine in chronic pain management: an evidence-based review. Anesth Analg 2003, 97:1730-1739.
38. Duflo F, Li X, Bantel C, et al. Peripheral nerve injury alters the alpha2 adrenoceptor subtype activated by clonidine for analgesia. Anesthesiology 2002, 97:636-641.
39. Wallace M Dose-dependent effects of smoked cannabis on capsaicin-induced pain and hyperalgesia in healthy volunteers. Anesthesiology 2007, 107:785-796.
40. Gorter RW, Butorac M, Cobian EP, van der Sluis W Medical use of cannabis in the Netherlands. Neurology 2005, 64:917-919.
41. Tesfaye S, Watt J Electrical spinal-cord stimulation for painful diabetic peripheral neuropathy. Lancet 1996, 348:1696-1701.
42. Dellon AL, et al. Practice advisory: utility of surgical decompression for treatment of diabetic neuropathy: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 2007, 68:796.
43. Abusaisha BB, Constanzi JB, Boulton AJM Acupuncture for the treatment of chronic painful diabetic neuropathy: a long-term study. Diabetes Res Clin Pract 1998, 39:115-121.